Citizens & Northern Corp (CZNC) stock
CZNCNasdaqState Commercial BanksFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3031% above fair value
$27.43−0.57 (-2.04%)
Close on Nov 17, 2026Market cap $491.95MP/E 18.5Yield –
Citizens & Northern EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Citizens & Northern's EPS for the twelve months ending Jun 30, 2026 was $1.48, down 15.4% year over year. For fiscal 2024 it was $1.69, up 7.6% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $1.92 in fiscal 2011.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.69 | +7.6% |
| FY2023 | Dec 31, 2023 | $1.57 | -8.2% |
| FY2022 | Dec 31, 2022 | $1.71 | -10.9% |
| FY2021 | Dec 31, 2021 | $1.92 | +47.7% |
| FY2020 | Dec 31, 2020 | $1.30 | -11.0% |
| FY2019 | Dec 31, 2019 | $1.46 | -18.4% |
| FY2018 | Dec 31, 2018 | $1.79 | +62.7% |
| FY2017 | Dec 31, 2017 | $1.10 | -15.4% |
| FY2016 | Dec 31, 2016 | $1.30 | -3.7% |
| FY2015 | Dec 31, 2015 | $1.35 | -2.2% |
| FY2014 | Dec 31, 2014 | $1.38 | -8.0% |
| FY2013 | Dec 31, 2013 | $1.50 | -18.9% |
| FY2012 | Dec 31, 2012 | $1.85 | -3.6% |
| FY2011 | Dec 31, 2011 | $1.92 | +32.4% |
| FY2010 | Dec 31, 2010 | $1.45 | – |
| FY2009 | Dec 31, 2009 | -$4.40 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0.79 | +97.5% |
| Q1 FY2026 | Mar 31, 2026 | $0.02 | -95.1% |
| Q4 FY2025 | Dec 31, 2025 | $0.25 | -52.8% |
| Q3 FY2025 | Sep 30, 2025 | $0.42 | +2.4% |
| Q2 FY2025 | Jun 30, 2025 | $0.40 | 0.0% |
| Q1 FY2025 | Mar 31, 2025 | $0.41 | +17.1% |
| Q4 FY2024 | Dec 31, 2024 | $0.53 | +89.3% |
| Q3 FY2024 | Sep 30, 2024 | $0.41 | -18.0% |
| Q2 FY2024 | Jun 30, 2024 | $0.40 | +2.6% |
| Q1 FY2024 | Mar 31, 2024 | $0.35 | -12.5% |
| Q4 FY2023 | Dec 31, 2023 | $0.28 | -44.0% |
| Q3 FY2023 | Sep 30, 2023 | $0.50 | +72.4% |
| Q2 FY2023 | Jun 30, 2023 | $0.39 | -18.7% |
| Q1 FY2023 | Mar 31, 2023 | $0.40 | -9.1% |
| Q4 FY2022 | Dec 31, 2022 | $0.50 | +8.7% |
| Q3 FY2022 | Sep 30, 2022 | $0.29 | -38.3% |
| Q2 FY2022 | Jun 30, 2022 | $0.48 | +9.1% |
| Q1 FY2022 | Mar 31, 2022 | $0.44 | -20.0% |
| Q4 FY2021 | Dec 31, 2021 | $0.46 | +7.0% |
| Q3 FY2021 | Sep 30, 2021 | $0.47 | +161.1% |
| Q2 FY2021 | Jun 30, 2021 | $0.44 | +12.8% |
| Q1 FY2021 | Mar 31, 2021 | $0.55 | +83.3% |
| Q4 FY2020 | Dec 31, 2020 | $0.43 | +7.5% |
| Q3 FY2020 | Sep 30, 2020 | $0.18 | -53.8% |
| Q2 FY2020 | Jun 30, 2020 | $0.39 | +44.4% |
| Q1 FY2020 | Mar 31, 2020 | $0.30 | -26.8% |
| Q4 FY2019 | Dec 31, 2019 | $0.40 | -13.0% |
| Q3 FY2019 | Sep 30, 2019 | $0.39 | -13.3% |
| Q2 FY2019 | Jun 30, 2019 | $0.27 | -48.1% |
| Q1 FY2019 | Mar 31, 2019 | $0.41 | +13.9% |
| Q4 FY2018 | Dec 31, 2018 | $0.46 | +187.5% |
| Q3 FY2018 | Sep 30, 2018 | $0.45 | +40.6% |
| Q2 FY2018 | Jun 30, 2018 | $0.52 | +52.9% |
| Q1 FY2018 | Mar 31, 2018 | $0.36 | +28.6% |
| Q4 FY2017 | Dec 31, 2017 | $0.16 | -54.3% |
| Q3 FY2017 | Sep 30, 2017 | $0.32 | -5.9% |
| Q2 FY2017 | Jun 30, 2017 | $0.34 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.28 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.35 | – |
| Q3 FY2016 | Sep 30, 2016 | $0.34 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?